ECSP993016A - THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR - Google Patents
THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATORInfo
- Publication number
- ECSP993016A ECSP993016A ECSP993016A ECSP993016A EC SP993016 A ECSP993016 A EC SP993016A EC SP993016 A ECSP993016 A EC SP993016A EC SP993016 A ECSP993016 A EC SP993016A
- Authority
- EC
- Ecuador
- Prior art keywords
- paratoroid
- compositions
- estrogen receptor
- selective estrogen
- combinations including
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Esta invención se refiere a composiciones farmacéuticas de combinación y a procedimientos que comprenden (-) -cis-6-fenil-5-(4-(2-pirrolidin-1-il-etoxi)-fenil-5,6,7,8-tetrahidronaftalen-2-ol, o una de sus sales farmacéuticamente aceptables y hormona paratoroidea, o uno de sus fragmentos biológicamente activos, a procedimientos para usar dichas composiciones y a estuches que contienen dichas composiciones. Las composiciones son útiles para tratar fragilidad musculoesquelética, incluyendo osteoporosis, fractura osteoporótica, masa ósea reducida y fragilidad.This invention relates to combination pharmaceutical compositions and processes comprising (-) -cis-6-phenyl-5- (4- (2-pyrrolidin-1-yl-ethoxy) -phenyl-5,6,7,8- tetrahydronaphthalen-2-ol, or one of its pharmaceutically acceptable salts and paratoroid hormone, or one of its biologically active fragments, to procedures for using said compositions and to kits containing said compositions.The compositions are useful for treating musculoskeletal fragility, including osteoporosis, osteoporotic fracture, reduced bone mass and fragility.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP993016 ECSP993016A (en) | 1999-06-15 | 1999-06-15 | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP993016 ECSP993016A (en) | 1999-06-15 | 1999-06-15 | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP993016A true ECSP993016A (en) | 1999-08-12 |
Family
ID=42044005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP993016 ECSP993016A (en) | 1999-06-15 | 1999-06-15 | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP993016A (en) |
-
1999
- 1999-06-15 EC ECSP993016 patent/ECSP993016A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU18400A (en) | Prostaglandin agonists and their use to treat bone disorders | |
IS5468A (en) | Use of estrogen for the manufacture of a medicinal product for the treatment of menopause | |
ECSP055738A (en) | ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ- [b, f] -AZEPIN-5-CARBOXAMIDE AND ITS NEW GLASS FORMS | |
YU7797A (en) | Combination therapy for osteosis | |
BR9714155A (en) | Prevention of bone mass loss and replacement by certain prostaglandin agonists. | |
UY26130A1 (en) | COMPOUNDS TO TREAT OBESITY | |
AP9801269A0 (en) | Prostaglandin agonists. | |
PA8471201A1 (en) | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE STROGEN RECEPTOR AND PARATHYROID HORMONE MODULATOR | |
CY1117666T1 (en) | 4 - ((FAOXYLYL) SULFUR) -PHEOXIC ACIDS FOR USE IN THERAPEUTIC MEDICINE PURPOSES | |
DE60233261D1 (en) | INHIBITORS OF HUMAN ADAM-10 | |
ID18079A (en) | PHARMACEUTICAL COMPOSITION THAT CONTAINS FASTEST OSTEOGENESIS | |
ATE171873T1 (en) | ANTIGLUCOCORTICOID STEROIDS FOR THE TREATMENT OF ANXIETY DISORDERS | |
NO20040598L (en) | 5-CNAC as an oral delivery agent for parathyroid hormone fragments. | |
SE9801495D0 (en) | Protein formulation | |
DK1525215T3 (en) | Modulators for the progesterone receptor with elevated anti-gonadotropic activity for women's fertility control and hormone replacement therapy | |
ECSP993016A (en) | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR | |
HUP0202396A2 (en) | Medicaments useful for treating fractures | |
PA8475901A1 (en) | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY | |
NO20006381L (en) | Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents | |
BR0212834A (en) | Formulations and use thereof | |
DE69916932D1 (en) | Combination therapeutic agents containing a selective estrogen receptor modulator and prostaglandin E2 | |
ECSP993020A (en) | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY | |
IT1307866B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING INHIBITORS OF GROWTH HORMONE OR THEIR BIOLOGICALLY ACTIVE FRAGMENTS FOR TREATMENT | |
UY26651A1 (en) | COMBINED THERAPY FOR OSTEOPOROSIS | |
UA28851A (en) | Method of operative treatment of the tibia distal epiphysis fructures |